Flunixin Meglumine Injectable

302 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

302

Total Reports

115

Deaths Reported

3810.0%

Death Rate

Active Ingredients

Flunixin Meglumine Injectable

Administration Routes

UnknownIntravenousIntramuscularSubcutaneousOralTopicalIntraocularOtherOphthalmicIntravesical

Species Affected

Horse 120

Cattle 78

Unknown 49

Human 21

Pig 8

Dog 6

Sheep 5

Goat 5

Other Equids 3

Cat 2

Most Affected Breeds

Unknown 74

Quarter Horse 37

Cattle (other) 21

Holstein-Friesian also known as Holstein 14

Aberdeen Angus 11

Crossbred Bovine/Cattle 10

Warmblood (unspecified) 9

Thoroughbred 9

Red Angus 6

Horse (unknown) 6

Most Reported Reactions

Death 81

Lack of efficacy - NOS 48

Contamination, Particulate Matter 28

Injection site swelling 23

INEFFECTIVE, ANTIINFLAMMATORY 22

Death by euthanasia 22

Colic 18

Fever 16

Injection site pain 15

Lack of efficacy (bacteria) - NOS 13

Anaphylaxis 12

Appearance, Abnormal 12

Outcome Breakdown

Died

92 (30.7%)

Recovered/Normal

81 (27.0%)

Ongoing

70 (23.3%)

Outcome Unknown

30 (10.0%)

Euthanized

24 (8.0%)

Recovered with Sequela

3 (1.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.